Joanna Sax - California Western
Associate Professor of Law
Co-Director, Institute of Health Law Studies
J.D., University of Pennsylvania Law School
Ph.D., University of Pennsylvania School of Medicine [Cell and Molecular Biology]
B.S., University of Wisconsin [Zoology]
Contracts; Law, Science and Medicine; Trusts & Estates
Professor Sax joined the California Western faculty in 2009. She earned a law degree from University of Pennsylvania. After law school, Professor Sax was an associate in the San Francisco office of Morgan, Lewis & Bockius LLP, where she litigated a wide variety of cases in state and federal court. Prior to law school, Professor Sax received a Ph.D. in Cell and Molecular Biology from the University of Pennsylvania School of Medicine. Professor Sax's research combines her scientific background and legal education to focus on issues in biomedical policy and the life sciences.
Joanna K. Sax, The Separation of Politics and Science, __ Stan. J. L. Sci. and Pol’y __ (forthcoming 2014).
Joanna K. Sax, Precautionary Principle, Value of a Statistical Life and Fracking, __ J. of Law, Med. & Ethics __ (forthcoming 2014).
Joanna K. Sax, The Tobacco Diaries: Lessons Learned and Applied to Regulation of Dietary Supplements, 73 Md. L. Rev. Endnotes 20 (2013).
Joanna K. Sax, Application of Default Rules to Address Financial Conflicts of Interest in Academic Medical Centers, 87 Ind. L. J. Supp. 53 (2012).
Joanna K. Sax, Financial Conflicts of Interest in Science, 21 Loy. Annals Health L. 291 (2012).
Joanna K. Sax, Evaluation of Academic Scientists' Responses to Situations that Pose a Conflict of Interest, 12 Cancer Biology & Therapy 4 (2011) (with Doran, N.).
Joanna K. Sax, Protecting Scientific Integrity: The Commercial Speech Doctrine Applied to Industry Publications, 37 Am. J. L. & Med. 203 (2011) (symposium).
Joanna K. Sax, Access to Prescription Drugs: A Normative Economic Approach to Pharmacist Conscience Clause Legislation, 63 Me. L. Rev. 89 (2010).
Joanna K. Sax, Reforming FDA Policy for Pediatric Testing: Challenges and Changes in the Wake of Studies Using Anti-Depressant Drugs, 4 Ind. Health L. Rev. 62 (2007).
Joanna K. Sax, The States “Race” with the Federal Government for Stem-Cell Research, 15 Loy. Annals Health L. 1 (2006).
Innovation, Public Health & Cost-Benefit Analysis, ASLME 2014 Health Law Professors Conference, Hastings Law School, June 2014.
Revisiting the Role of the Value of a Statistical Life Through Fracking, American Association of Law Schools Annual Meeting, New York, NY., January 2014.
Playing Politics: How the Political Game Impacts the Advancement of Science, Southeastern Association of Law Schools Annual Meeting, Palm Beach, FL., August 2013.
How Politics Impacts the Advancement of Biomedical Science, ASLME 2013 Health Law Professors Conference, Seton Hall Law School, June 2013.
The Tobacco Diaries: Lessons Learned and Applied to Regulation of Dietary Supplements, The Food and Drug Administration in the 21st Century, Harvard Law School, May 2013.
Strengthening Financial Conflict of Interest Rules at Academic Medical Centers, 2012 Law & Society Annual Meeting, Honolulu, HI.
Conflicts of Interest in Biomedical Science, 2011 Law & Society Annual Meeting, San Francisco, CA.
Protecting Scientific Integrity: The Commercial Speech Doctrine Applied to Industry Publications, Symposium: Marketing Health: The Growing Role of the Commercial Speech Doctrine in Health Regulation, Boston University School of Law, February 2011.
Access to Prescription Drugs: A Normative Economic Approach Calls for an End to Conscience Clause Legislation, The 2009-2010 Biomedical Ethics Seminar Series, University of California San Diego School of Medicine.
Access to Prescription Drugs: A Normative Economic Approach Calls for an End to Conscience Clause Legislation, 2010 Law & Society Annual Meeting, Chicago, Il.